Trigger-responsive engineered-nanocarriers and image-guided theranostics for rheumatoid arthritis

Nanoscale
Nadim AhamadRinti Banerjee

Abstract

Rheumatoid Arthritis (RA), one of the leading causes of disability due to progressive autoimmune destruction of synovial joints, affects ∼1% of the global population. Standard therapy helps in reducing inflammation and delaying the progression of RA but is limited by non-responsiveness on long-term use and several side-effects. The conventional nanocarriers (CNCs), to some extent, minimize toxicity associated with free drug administration while improving the therapeutic efficacy. However, the uncontrolled release of the encapsulated drug even at off-targeted organs limits the application of CNCs. To overcome these challenges, trigger-responsive engineered nanocarriers (ENCs) have been recently explored for RA treatment. Unlike CNCs, ENCs enable precise control over on-demand drug release due to endogenous triggers in arthritic paws like pH, enzyme level, oxidative stress, or exogenously applied triggers like near-infrared light, magnetic field, ultrasonic waves, etc. As the trigger is selectively applied to the inflamed joint, it potentially reduces toxicity at off-target locations. Moreover, ENCs have been strategically coupled with imaging probe(s) for simultaneous monitoring of ENCs inside the body and facilitate an 'image-g...Continue Reading

References

Jul 1, 1971·Arthritis and Rheumatism·P S Treuhaft, D J MCCarty
Jun 1, 1994·Arthritis and Rheumatism·N J Zvaifler, G S Firestein
Jan 1, 1994·Journal of Biomedical Materials Research·A S ShanbhagT T Glant
Feb 14, 1998·The Journal of Clinical Investigation·G A SchellekensW J van Venrooij
May 18, 1999·Rheumatology·G SteinerJ S Smolen
Sep 1, 2000·Science·S L Teitelbaum
Nov 30, 2000·The New England Journal of Medicine·P E LipskyUNKNOWN Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
Mar 22, 2001·The New England Journal of Medicine·E H Choy, G S Panayi
May 29, 2001·Journal of Biomedical Optics·J E ChomasK Ferrara
Dec 18, 2001·Advanced Drug Delivery Reviews·P Meers
Feb 21, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fakhrul AhsanAna I Torres Suarez
Apr 16, 2002·Arthritis and Rheumatism·Elena NeumannUlf Müller-Ladner
Aug 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Takeshi ItohRyuji Suzuki
Mar 5, 2004·Journal of Pharmaceutical Sciences·Linda S LiangHelen M Burt
Nov 24, 2005·International Journal of Pharmaceutics·Donald E Owens, Nicholas A Peppas
May 26, 2007·Nature Reviews. Immunology·Iain B McInnes, Georg Schett
Jun 16, 2007·Lancet·Josef S SmolenPaul Emery
Feb 29, 2008·Journal of Pharmaceutical Sciences·Claus LarsenPia H Andersen
Apr 1, 2008·Pharmaceutical Research·Julie A ChampionSamir Mitragotri
Apr 15, 2008·Ultrasound in Medicine & Biology·Shao-Ling HuangRobert C Macdonald
Jun 17, 2008·Advanced Drug Delivery Reviews·Partha GhoshVincent M Rotello
Dec 20, 2008·Nature Materials·Samir Mitragotri, Joerg Lahann
Jul 15, 2009·Biochimica Et Biophysica Acta·Shyh-Dar Li, Leaf Huang
Sep 29, 2009·Colloids and Surfaces. B, Biointerfaces·Avnesh KumariSubhash C Yadav

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques
imaging technique

Clinical Trials Mentioned

NCT00241982

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Nanomaterials
Santhosh Kalash RajendrakumarIn-Kyu Park
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Yamini MadavBala Prabhakar
© 2022 Meta ULC. All rights reserved